文献速递胸部肿瘤放疗放疗物理与技术

简易间质性肺异常评分可预测局部晚期非小细胞肺癌根治性放疗后需激素治疗的放射性肺炎

Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer.
PubMed 文献 · Adv Radiat Oncol · 2020-10-31

本研究纳入145例接受根治性放疗的局部晚期非小细胞肺癌患者,由3名诊断放射科医师基于放疗前胸部CT评定简易间质性肺异常评分(ILAS)。多因素分析显示仅ILAS(P = .001)为独立预测因素。

要点

  • 简易ILAS由3名放射科医师基于放疗前CT评定,评分0为无异常、1为无蜂窝状改变、2为蜂窝状改变。
  • 多因素分析中仅ILAS(P = .001)为steroid-RP独立预测因素。

核心结论

  • 简易ILAS是一种易用工具,是LA-NSCLC患者根治性放疗后steroid-RP的显著预测因素。

研究设计与样本

  • 回顾性研究,纳入2014年1月至2017年5月在本机构接受根治性放疗的145例LA-NSCLC患者。
  • 由3名诊断放射科医师评估放疗前胸部CT并确定简易ILAS。
  • 分析ILAS、体能状态、年龄、呼吸功能、Brinkman指数、同步化疗及肺剂量体积直方图指标与steroid-RP的关联。

主要发现

  • 单因素分析中肺V5/V10/VS5、Brinkman指数和ILAS为steroid-RP的显著预测因素。
  • 多因素分析纳入Brinkman指数≥840、肺V5≥37%和ILAS≥1,仅ILAS(P = .001)为独立预测因素。

关键数值与推荐

  • ILAS评分:0为无异常;1为无蜂窝状改变的异常(磨玻璃衰减、细网状混浊和小囊);2为蜂窝状改变。
  • 多因素分析变量包括Brinkman指数≥840、肺V5≥37%和ILAS≥1。

临床怎么用

  • 放疗前可用简易ILAS辅助识别steroid-RP高风险患者,以指导激素使用决策并考虑对免疫治疗效果的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Adjuvant durvalumab has become a standard treatment after chemoradiation therapy for patients with locally advanced non-small cell lung cancer (LA-NSCLC). Accordingly, predicting radiation pneumonitis (RP) requiring steroidal treatment (steroid-RP) is of utmost importance because steroidal administration is reported to weaken the effectiveness of immunotherapy. However, grade 2 RP was used as an index of RP in previous studies, but it is an ambiguous definition because it includes not only steroid-RP but also a mild cough requiring only a cough medicine. Therefore, in this study, steroid-RP was used for evaluating RP, and the purpose of this study was to investigate predictive factors of steroid-RP, including original simple interstitial lung abnormality scores (ILASs). METHODS AND MATERIALS: A total of 145 patients with LA-NSCLC who received definitive radiation therapy (DRT) in our institution from January 2014 to May 2017 were identified. Original ILASs, performance status, age, respiratory function, Brinkman index, concurrent administration of chemotherapy, and dose-volume histogram metrics of the lung were analyzed to evaluate their association with steroid-RP. Additionally, 3 diagnostic radiologists evaluated the patients' pre-DRT chest computed tomography images and determined the simple ILASs. ILASs were rated as follows: 0: none; 1: abnormality without honeycombing (ground-glass attenuation, fine reticular opacity, and microcysts); and 2: honeycombing. RESULTS: The median follow-up period was 729 days. Thirty-one patients (21.4%) experienced steroid-RP. In the univariate analysis, lung V5/V10/VS5, Brinkman index, and ILASs were significant predictive factors of steroid-RP. Additionally, multivariate analysis including Brinkman index ≥840, lung V5 ≥37%, and an ILAS ≥1 revealed that only an ILAS (P = .001) was an independent predictive factor of steroid-RP. CONCLUSIONS: The original simple ILAS was an easy-to-use tool and a significant predictive factor of steroid-RP in DRT in patients with LA-NSCLC.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kashihara T, Nakayama Y, Ito K, et al. Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer. Adv Radiat Oncol. 2020. PMID: 33665489. doi:10.1016/j.adro.2020.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。